Wolverine Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Wolverine Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-103,902	Closed	-$3.51M	–	2741
2021 Q2	$3.51M	Buy	+103,902	New	+$2.65M	0.03%	328

Wolverine Asset Management's CNST Position: Q3 2021 in Review

Wolverine Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 103,902 shares — an estimated $3.51M sold.

Wolverine Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $3.51M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Wolverine Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Wolverine Asset Management sold 103,902 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3.51M.
Wolverine Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Wolverine Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $3.51M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.